ASCO 2025: Profiling The Biggest Presentations At The Biggest Cancer Meeting
Source: SeekingAlpha
2025-06-09 08:45:00 ET
ASCO 2025 Overview
Prior to the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, I put together a preview article focused on the biotech-related stories coming out of the various oral presentations at the meeting, broken out by disease area....
Read the full article on Seeking Alpha
For further details see:
ASCO 2025: Profiling The Biggest Presentations At The Biggest Cancer Meeting
Takeda Pharmaceutical Company Limited American Depositary Shares
NASDAQ: TAK
TAK Trading
0.17% G/L:
$17.85 Last:
1,296,138 Volume:
$17.92 Open:
TAK Latest News
March 02, 2026 02:00:00 am
Takeda and Protagonist Announce U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Rusfertide as a Potential First-in-Class Therapy for Polycythemia Vera
February 24, 2026 09:35:00 am
Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity
TAK Stock Data
$57,107,745,653
3,115,826,299
N/A
157
N/A
Pharmaceuticals
Healthcare
JP
Chuo-ku
